Drugplain

Gentamicin Sulfate 40 mg/mL

GENTAMICIN SULFATE · INJECTION, SOLUTION · Medical Purchasing Solutions, LLC

10 Recalls on Record
Plain English

Gentamicin Sulfate is a injection, solution containing gentamicin sulfate at 40 mg/mL, taken intramuscular. Manufactured by Medical Purchasing Solutions, LLC.

Key Facts

Brand Name
Gentamicin Sulfate
Generic Name
GENTAMICIN SULFATE
NDC Code (Product)
71872-7337
Manufacturer
Medical Purchasing Solutions, LLC
Strength
40 mg/mL
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR, INTRAVENOUS
Marketing Status
Application #
ANDA062420
Marketing Start
08/29/2005

Recall History

10 Recalls on Record
Class II03/25/2013

Pallimed Solutions

Lack of Assurance of Sterility; FDA inspectional findings resulted in concerns associated with quality control procedures that impacted sterility assurance

TerminatedVoluntary: Firm initiated
Class II03/15/2022

Teligent Pharma, Inc.

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

TerminatedVoluntary: Firm initiated
Class II05/02/2013

Hospira Inc.

Presence of Particulate Matter: visible particles were identified floating in the primary container.

TerminatedVoluntary: Firm initiated
Class II03/15/2022

Teligent Pharma, Inc.

cGMP deviations: all products within expiry are being recalled because the firm is discontinuing its stability study program.

TerminatedVoluntary: Firm initiated
Class II05/29/2013

Lowlite Investments, Inc. D/B/A Olympia Pharmacy

Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processes

OngoingVoluntary: Firm initiated
Class II02/22/2019

Akorn, Inc.

Failed Impurities/Degradation Specifications: High Out-of-Specification (OOS) results for Individual and Total Impurities that have been identified at the 18 months stability testing time point.

TerminatedVoluntary: Firm initiated
Class II10/08/2018

Akorn, Inc.

Presence of Particulate Matter: Crystalline particles were noticed at the 24 month clarity testing.

TerminatedVoluntary: Firm initiated
Class II02/22/2017

Advanced Pharma Inc.

Labeling: Not Elsewhere Classified: Products may contain synthetic latex and/or natural latex.

TerminatedVoluntary: Firm initiated
Class II10/06/2014

Oregon Compounding Centers, Inc. dba Creative Compounds

Lack of Sterility Assurance: All lots of sterile products compounded by the pharmacy that are not expired due to concerns associated with quality control procedures that present a potential risk to sterility assurance that were observed during a recent FDA inspection.

TerminatedVoluntary: Firm initiated
Class II05/28/2015

Lincare, Inc.

Lack of Assurance of Sterility: Sterility of product is not assured.

TerminatedVoluntary: Firm initiated

Side Effects Reported to FDA

FDA FAERS database · These are reported events, not confirmed side effects

drug ineffective188 reports
acute kidney injury173 reports
off label use159 reports
drug hypersensitivity153 reports
pyrexia138 reports
rash113 reports
renal failure acute105 reports
nausea104 reports
renal failure98 reports
pneumonia96 reports

Full Prescribing Information

Source: FDA Drug Label (SPL)For healthcare professionals

Indications & Usage

INDICATIONS AND USAGE Gentamicin sulfate ophthalmic solution is indicated in the topical treatment of ocular bacterial infections including conjunctivitis, keratitis, keratoconjunctivitis, corneal ulcers, blepharitis, blepharoconjunctivitis, acute meibomianitis, and dacryocystitis, caused by susceptible strains of the following microorganisms: Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pyogenes, Streptococcus pneumoniae, Enterobacter aerogenes, Escherichia coli, Haemophilus influenzae, Klebsiella pneumoniae, Neisseria gonorrhoeae, Pseudomonas aeruginosa, and Serratia marcescens.

Dosage & Administration

DOSAGE AND ADMINISTRATION Instill one or two drops into the affected eye(s) every four hours. In severe infections dosage may be increased to as much as two drops every hour.

Warnings

WARNINGS NOT FOR INJECTION INTO THE EYE Gentamicin sulfate ophthalmic solution is not for injection. It should never be injected subconjunctivally, nor should it be directly introduced into the anterior chamber of the eye.

Contraindications

CONTRAINDICATIONS Gentamicin sulfate ophthalmic solution is contraindicated in patients with known hypersensitivity to any of its components.

Adverse Reactions

ADVERSE REACTIONS Bacterial and fungal corneal ulcers have developed during treatment with gentamicin ophthalmic preparations. The most frequently reported adverse reactions are ocular burning and irritation upon drug instillation, non-specific conjunctivitis, conjunctival epithelial defects and conjunctival hyperemia. Other adverse reactions which have occurred rarely are allergic reactions, thrombocytopenic purpura and hallucinations. To report SUSPECTED ADVERSE REACTIONS, contact Bausch & Lomb Incorporated at 1-800-553-5340 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Frequently Asked Questions

What is Gentamicin Sulfate used for?

Gentamicin Sulfate contains GENTAMICIN SULFATE. It is a injection, solution taken intramuscular. Consult your doctor for specific uses.

Is Gentamicin Sulfate a controlled substance?

Gentamicin Sulfate is not classified as a controlled substance by the DEA.

What is the generic name for Gentamicin Sulfate?

The generic name for Gentamicin Sulfate is GENTAMICIN SULFATE. There are 4 other brand versions of GENTAMICIN SULFATE.

What is the NDC code for Gentamicin Sulfate 40 mg/mL?

The NDC (National Drug Code) for Gentamicin Sulfate 40 mg/mL is 71872-7337, listed by Medical Purchasing Solutions, LLC.